GoodRx Holdings, Inc. (GDRX) Operating Income (Loss) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
GoodRx Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
  • GoodRx Holdings, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was $7.38 M, a 34.7% decline year-over-year.
  • GoodRx Holdings, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$30.9 M, a 360% decline year-over-year.
  • GoodRx Holdings, Inc. annual Operating Income (Loss) for 2023 was -$27 M, a 1654% decline from 2022.
  • GoodRx Holdings, Inc. annual Operating Income (Loss) for 2022 was $1.74 M, a 87% decline from 2021.
  • GoodRx Holdings, Inc. annual Operating Income (Loss) for 2021 was $13.4 M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$30.9 M $7.38 M -$3.92 M -34.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$27 M -$18.3 M -$20 M -1153% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$6.98 M -$38.3 M -$22.6 M -144% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $15.6 M $18.3 M +$22.4 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$6.72 M $11.3 M -$8.46 M -42.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.74 M $1.74 M -$10 M -85.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $11.8 M -$15.7 M -$22.7 M -325% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $34.5 M -$4.05 M -$3.7 M -1053% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $38.2 M $19.8 M +$24.8 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $13.4 M $11.8 M +$311 M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$298 M $7 M +$68.7 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$366 M -$351 K -$42.1 M -101% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$324 M -$5 M -$48.7 M -111% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$276 M -$299 M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$61.7 M -$99.5 M -263% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $41.7 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $43.7 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 $37.8 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.